BRCA1 and STMN1 as prognostic markers in NSCLCs who received cisplatin-based adjuvant chemotherapy

OBJECTIVE: In this study, we aimed to investigate the predictive effect of BRCA1, STMN1, MAPT and TUBB3 on the prognosis of patients with non-small cell lung cancer (NSCLC). METHODS: Seventy NSCLC patients who received platinum-based chemotherapy from June 2009 to July 2011 were enrolled. The protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mingxing, Li, Wanjun, Xing, Xuemei, Zhang, Dan, Lei, Jie, Li, Guoyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655245/
https://www.ncbi.nlm.nih.gov/pubmed/29113350
http://dx.doi.org/10.18632/oncotarget.20715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655245/
https://www.ncbi.nlm.nih.gov/pubmed/29113350
http://dx.doi.org/10.18632/oncotarget.20715

Ejemplares similares